Plexus Corp (NASDAQ:PLXS) shares have reached an unprecedented peak, touching an all-time high of $170.09, signaling a period of significant bullish momentum for the company. According to InvestingPro analysis, the stock is currently trading above its Fair Value, with a P/E ratio of 40.8x suggesting a premium valuation. This milestone reflects a remarkable 68.79% surge in the stock's value over the past year, underscoring investor confidence and the firm's robust performance in its market segment. The company maintains a healthy financial position with an overall "GOOD" health score, and analysts forecast EPS of $7.20 for fiscal year 2025. The ascent to this record price level not only highlights the company's recent achievements but also sets a new benchmark for its financial prospects, as market participants continue to closely monitor Plexus's trajectory in the face of dynamic economic conditions. Discover 11 additional key insights about PLXS with an InvestingPro subscription, including exclusive analysis in our comprehensive Pro Research Report.
In other recent news, Plexus Corp has been the subject of several analyst notes. Needham increased its price target for Plexus to $162.00, maintaining a Buy rating, following a 3% year-over-year increase in the company's FQ4 revenue and a strong EPS forecast for the first quarter of Fiscal Year 2025. The firm highlighted Plexus's robust free cash flow as indicative of the company's strong cash generation capabilities.
Meanwhile, KeyBanc initiated coverage on Plexus with a Sector Weight rating, acknowledging the company's strong design capabilities and strategic market positioning. The firm projects Plexus's high single-digit percentage revenue growth and margin improvements could lead to a 12% compound annual growth rate in earnings per share from 2025 to 2027. However, KeyBanc also noted that Plexus's stock is trading at a premium, approximately five times higher than the average of its peers.
Benchmark maintained a Buy rating for Plexus and increased its price target to $150 from $145. The firm expects new initiatives in the Space and Semiconductor Capital Equipment sectors to offset the impact of the ongoing Boeing (NYSE:BA) strike on Plexus's near-term revenues. In addition, Plexus secured over $500 million in contracts in the healthcare life sciences sector over the past four quarters.
Lastly, Plexus reported strong financial performance in its fiscal third quarter of 2024 with revenues of $961 million and free cash flow of $114 million. The company also announced a new $50 million stock buyback plan, following the conclusion of its ongoing initiative. These are among the recent developments for Plexus.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.